Benitec Biopharma (BNTC) Change in Cash (2019 - 2025)

Benitec Biopharma has reported Change in Cash for 7 years, with the latest figure at $94.3 million in Q4 2025.

• Quarterly Change in Cash rose 803.36% year-over-year to $94.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $110.6 million (up 90.76% YoY) and the FY2025 annual result came in at $46.9 million, down 3.12% from the prior year.
• Change in Cash advanced to $94.3 million in Q4 2025 per BNTC's latest filing, from -$3.3 million in the prior quarter.
• Over five years, Change in Cash peaked at $94.3 million in Q4 2025 and troughed at -$6.2 million in Q1 2024.
• A 5-year average of $8.7 million and a median of -$3.3 million in 2021 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 158.72% in 2022, then soared 1002.4% in 2024.
• Over 5 years, Change in Cash stood at -$3.4 million in 2021, then plunged by 76.46% to -$6.0 million in 2022, then climbed by 8.46% to -$5.5 million in 2023, then surged by 290.2% to $10.4 million in 2024, then soared by 803.36% to $94.3 million in 2025.
• According to Business Quant data, Change in Cash over the past three periods registered $94.3 million, -$3.3 million, and -$5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.